This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc., Board Nf Regents the Inivercitvof Texas Cvctom, Iovance Biotherapeutics, Inc.. Active years: 2018-2026.
Company Filing History:
3 out of 311 
1 out of 1 
1 out of 110 
Years Active: 2018-2026
Title: The Innovative Contributions of Jeffrey S Weber
Introduction
Jeffrey S Weber is a prominent inventor based in Tampa, FL (US), known for his significant contributions to the field of cancer research and therapy. With a total of 4 patents to his name, Weber has made strides in enhancing adoptive cell therapy, particularly through the expansion of tumor-infiltrating lymphocytes.
Latest Patents
One of Weber's latest patents focuses on the enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy. This innovative method involves culturing tumor fragments from a subject in a specialized culture medium containing IL-2 and a 41BB agonist. This approach effectively expands tumor-infiltrating lymphocytes, enriching their tumor-reactivity and specificity. Additionally, the patent outlines a method for treating tumors in subjects by administering nonmyeloablative lymphodepleting chemotherapy, followed by the introduction of the expanded tumor-infiltrating lymphocytes.
Career Highlights
Throughout his career, Jeffrey S Weber has worked with esteemed institutions such as the H. Lee Moffitt Cancer Center and Research Institute, Inc. and the Board of Regents of the University of Texas System. His work in these organizations has significantly contributed to advancements in cancer treatment methodologies.
Collaborations
Weber has collaborated with notable colleagues, including Bin Yu and Wenshi Wang, further enhancing the impact of his research and innovations in the field.
Conclusion
Jeffrey S Weber's innovative work in the expansion of tumor-infiltrating lymphocytes for adoptive cell therapy showcases his dedication to improving cancer treatment. His contributions continue to influence the field and offer hope for more effective therapies in the future.